Dergiler / Türk Kardiyoloji Derneği Arşivi / 2021 / Cilt: 49 - Sayı: 8

Araştırma bulgularının genelleştirilmesi ve taşınabilirliği: Randomize denemeler ve gözlemsel çalışmalar

Generalizability and transportability of research findings: Randomized trials vs observational studies

Sayfa
627–629
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

Tanboğa, İ. H., M.D., M., PhD, P., Birdal, O., M.D., M. (2022). Araştırma bulgularının genelleştirilmesi ve taşınabilirliği: Randomize denemeler ve gözlemsel çalışmalar. Türk Kardiyoloji Derneği Arşivi, Cilt: 49 - Sayı: 8, 627–629. https://ajindex.com/articles/631823

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Hoogland J, IntHout J, Belias M, Rovers MM, Riley RD, Harrell Jr FE, et al. A tutorial on individualized treatment effect prediction from randomized trials with a binary en- dpoint. Stat Med 2021;40:5961-81. [Crossref] 2. Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet 2005;365:82-93. [Crossref] 3. Rothwell PM. Factors that can affect the external validity of randomised controlled trials. PLoS Clin Trials 2006;1:e9. [Crossref] 4. Altın C, Topaloğlu C, Çetin N, Dalgıç O, Yavuz V, Alioğlu E, et al. Dabigatran’s stroke prevention in real life; a sample of population from Turkey: D-SPIRIT registry. Turk Kardi- yol Dern Ars 2021;49:630-40. 5. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldg- ren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. [Crossref] 6. Rothman KJ, Gallacher JE, Hatch EE. Why representative- ness should be avoided. Int J Epidemiol 2013;42:1012-4. [Crossref] 7. Bradburn MJ, Lee EC, White DA, Hind D, Waugh NR, Co- oke DD, et al. Treatment effects may remain the same even when trial participants differed from the target population. J Clin Epidemiol 2020;124:126-38. [Crossref] 8. Harrell F. Implications of interactions in treatment compari- sons. Statistical Thinking. 2020. Available at: https://www. fharrell.com/post/ia/. 9. Oude Rengerink K, Kalkman S, Collier S, Ciaglia A, Wors- ley SD, Lightbourne A, et al. Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challen- ges and consequences. J Clin Epidemiol 2017;89:173-80. [Crossref] 10. Degtiar I, Rose S. A review of generalizability and transpor- tability. 2021. arXiv:2102.11904. 11. Roche N, Reddel H, Martin R, Brusselle G, Papi A, Thomas M, et al. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc 2014;11:S99-104. [Crossref] 12. Hernan MA. Methods of public health research - strengthe- ning causal inference from observational data. N Engl J Med 2021;385:1345-8. [Crossref] 13. Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, et al. Control of confounding and reporting of results in causal inference studies. guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc 2019;16:22-8. [Crossref]